STEAP2 expression in prostate cancer was found to be significantly higher than that in normal tissues (Porkka et al., 2002; von Rozycki et al., 2004; Wang et al., 2010; Whiteland et al., 2014; Burnell et al., 2018, 2019). This evidence concerns the gene STEAP2 and prostate carcinoma.